Nigel Hughes is the Scientific Director of Real World Evidence at Janssen Clinical Innovation. He collaborates with the EFPIA Digital Strategic Governing Group, and he is also co-lead of Big Data for Better Outcome’s €30 million flagship consortium, the European Health Data & Evidence Network, or EHDEN. Janssen and Nigel have long been at the forefront of developing the needed tools and infrastructure to harness health data, both through their involvement with previous IMI projects such as EMIF and EHR4CR, as well as supporting open source data sharing platforms such as OMOP and OHDSI.

Nigel brings his decades of experience in nursing and directing NGOs in AIDS and Hepatitis C to IMI's EHDEN. His unique perspective on the need for global collaboration to address societal challenges like Alzheimer's disease is well-reasoned and refreshing in today's fractured and divisive political climate.

See omnystudio.com/listener for privacy information.

Dr. Clemens Martin Auer is currently Special Envoy for Health at the Austrian Federal Ministry of Labour, Social Affairs, Health and Consumer Protection and formerly longstanding Director General of the same institution. In this podcast, we discuss his leadership for implementation of better tools to evaluate healthcare efficiency and outcomes as the co-chair of the European eHealth Network to establish cross-border eHealth applications. In 2017, he was elected President of the European Health Forum Gastein, which under his direction has focused on improving the delivery of healthcare in the EU member states. He has been nominated by the Austrian Government to be the next WHO Regional Director for Europe, and we discuss his vision and objectives if he were to be successfully elected to that position.

See omnystudio.com/listener for privacy information.

Vaccines are one of the most effective public health measures available, saving some two to three million lives worldwide every year. However, in Europe where vaccine preventable disease almost disappeared, the public is now worried about the safety of the vaccine, limiting their use, resulting in outbreaks of preventable diseases like Measles. IMI’s Advance project, which concluded in March of 2019, brought together a large cross-section of European stakeholders to create a system and network to rapidly provide real world evidence on vaccine coverage, safety and effectiveness using existing health data in EU countries.

ADVANCE has built VAC4EU: a non-for profit legal entity that will implement the ADVANCE system and vision, and in this podcast we are joined by two members of the ADVANCE co-ordinating team responsible for its launch and rebranding.

Miriam Sturkenboom, ADVANCE’s Project Coordinator
Patrick Mahy, Scientific Institute of Public Health in Belgium

See omnystudio.com/listener for privacy information.

Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest, Prior to founding CMPI, Pitts was a Senior Fellow for healthcare studies at the Pacific Research Institute. From 2002-2004 Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting.

In this podcast, we discuss the potential impact of the International Pricing Index (IPI) on global innovation, as well as several alternatives which could be put in place that would create less havoc for innovators and patients. As well, we discuss the increasing divergence of the innovative capacity between the US and Europe, and how the current systems of reimbursement are impacting the ability to support and R&D ecosystem.

See omnystudio.com/listener for privacy information.

Joe Damond is the Executive Vice President for International Affairs at the Biotechnology Innovation Organization (BIO), the largest service organisation for biotech companies in the world. In this podcast we discuss the continuing attacks on Intellectual Property in Europe and the US, as well as how the International Pricing Index (IPI) of the Trump administration will impact biotech investment and innovation.

Joe spent 12 years as a trade negotiator at the Office of the United States Trade Representative for Asia and Pacific/APEC Affairs, and is a well-respected thought-leader helping governments develop sustainable biotech ecosystems. Joe Damond received his master’s degree from Princeton University’s Woodrow Wilson School of Public and International Affairs.

See omnystudio.com/listener for privacy information.

Vital Transformation launches its new series of Better Science, Better Health podcasts focused on the challenges and opportunities of new medicines. With the increasing focus on drug pricing in the US Congress and Senate, and with the Trump Administration's proposals for international reference pricing on therapies covered under Medicare Part B, Vital Transformation shares the insights of Dr. Mark McClellan, one of the world's most important thought leaders in value-based healthcare.

Mark McClellan is the founding Director of the Duke-Margolis Center for Health Policy at Duke University. He is a world-renowned physician and economist who has researched outcomes-based reimbursement and real-world evidence evaluation models for new therapies. Dr McClellan was both the former administrator of the Centers for Medicare & Medicaid Services and Commissioner of the FDA. He was a Senior Fellow in Economic Studies at the Brookings Institution, where he was the Director of the Health Care Innovation and Value Initiatives.

See omnystudio.com/listener for privacy information.

Martin Seychell, Deputy Director General for Health, Food and Safety of the European Commission, outlines how Europe must use a combination of social media communications and new real-time tools for safety monitoring to regain the public’s trust in vaccinations. Our Vital Health Podcast was recorded at the final event of the Innovative Medicine’s Initiative’s ADVANCE project, which promotes the use of distributed health databases to facilitate vaccine safety studies in Europe.

See omnystudio.com/listener for privacy information.

The Norwegian Medicine Agency’s Anja Schiel is on…

Sebastian Schneeweiss is Professor of Medicine an…

For five years, Tomas Salmonson was the chair of …